Alzheimer's Imaging Consortium

Andrew R Bender1, Pavithran Pattiam Giriprakash1, Zhengshi Yang1

  • 1Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA.

Abstract

Insights

Alzheimer's disease pathology, indicated by amyloid-beta (Aβ), alters white matter organization. Novel diffusion MRI measures like fiber dispersion show strong links to Aβ levels and cognitive function in older adults without dementia.

Area of Science:

  • Neuroimaging
  • Neurodegenerative Diseases
  • Biomarkers

Background:

  • Alzheimer's disease (AD) is linked to brain microstructure changes detectable by diffusion-weighted magnetic resonance imaging (dMRI).
  • Smaller, later-developing axons may be vulnerable in early AD, potentially detectable via dMRI measures of fiber density (FD) and dispersion.
  • This study investigates if amyloid-beta (Aβ) predicts FD and dispersion differences in non-demented older adults and their relation to cognition.

Purpose of the Study:

  • To determine if elevated amyloid-beta (Aβ) predicts differences in white matter fiber density (FD) and fiber dispersion using dMRI.
  • To assess the sensitivity of Aβ-associated microstructural parameters to cognitive function in older adults without dementia.
  • To explore the utility of fiber dispersion as a novel dMRI biomarker for early Alzheimer's pathology.

Main Methods:

  • 122 participants (cognitively unimpaired or mild cognitive impairment) underwent multi-shell dMRI and amyloid PET scans.
  • dMRI data were processed using MRtrix3 to model voxelwise total FD and fiber dispersion.
  • Mass-univariate analyses assessed Aβ (centiloid level) predicting FD and dispersion, controlling for covariates, with non-parametric familywise error rate correction.

Main Results:

  • Higher Aβ predicted reduced fiber dispersion in key brain regions (e.g., transcallosal, cingulum, hippocampus) but increased dispersion in cerebellar regions.
  • Fiber dispersion strongly correlated with Aβ centiloid levels (r = -0.78, p < .001).
  • Fiber dispersion significantly predicted cognitive performance across multiple domains (e.g., memory, executive function), whereas FD associations were weaker and age/sex-dependent.

Conclusions:

  • Amyloid-beta (Aβ) neuropathology is associated with altered white matter organization in adults without dementia.
  • Fiber dispersion is a novel dMRI measure highly correlated with Aβ-PET levels and cognitive function, independent of age and sex.
  • Combined modeling of fiber density and dispersion offers complementary insights into microstructural changes in early Alzheimer's pathology.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Imaging Studies III: Computed Tomography01:27

Imaging Studies III: Computed Tomography

DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
251
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
212
Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
629
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
460
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
758